Galenea have licensed Organix’s 5-HT2C agonists for the treatment of obesity and other related disorders.
Filed under: Uncategorized | Tagged: 5-ht2c, 5Ht2c, agonist, Galenea, Licensing | Leave a Comment »
Green Cross pubish series of CB1 antagonists
Posted on November 1, 2008 by crimsoncanary
Green Cross have published a series of biarylpyrazolyl oxadiazole based compounds as CB1 antagonists
Filed under: Uncategorized | Tagged: antagonist, Cannabinoid, Cannabinoid CB1, CB1, Green Cross | Leave a Comment »
Jenrin’s CB1 antagonists show efficacy with less adverse effects
Posted on November 1, 2008 by crimsoncanary
Data presented at the Annual Scientific Meeting of the Obesity Society show Jenrin’s CB1 antagonist are capable of having a metabolic effect while reducing risks of psychiatric side effects.
Filed under: Uncategorized | Tagged: antagonist, cannabin, Cannabinoid CB1, CB1, jenrin | Leave a Comment »
